Rounder Inc. Acquires Rights to its First Medical Product Formulation

WASHINGTON--(BUSINESS WIRE)--Rounder Inc., (Pink OTC Market: RNDR) medical division has acquired the formulation rights for a heart healthy nutraceutical product. Roughly one-third of adults use nutraceuticals and 15 million Americans use them together with conventional medicines. A study from the Mayo clinic found that 61% of those 18 years of age and older had used a nutraceutical over the past year. With sales of nutraceutical products increasing 25% per year in the United States, the US market for nutraceuticals is expected to reach $891 million in consumer purchases by 2013. Our capture of just a small percentage of market share in this rapidly growing industry segment should result in substantial revenue for the company.